Alector (ALEC) Change in Accured Expenses (2018 - 2026)
Alector (ALEC) posted quarterly Change in Accured Expenses of -$11.0 million for Q1 2026, up 13.35% year-over-year from -$9.7 million in Q1 2025, and down 1112.21% quarter-over-quarter from $1.1 million in Q4 2025.
Alector (ALEC) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Accured Expenses for 9 consecutive years, with -$11.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 13.35% year-over-year to -$11.0 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 439.22% YoY), while the FY2025 annual figure was -$12.9 million, down 3895.29% from the prior year.
- Change in Accured Expenses retreated to -$11.0 million in Q1 2026 per ALEC's latest filing, from $1.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $8.0 million in Q3 2023 and bottomed at -$12.7 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged -$1.4 million across 5 years, with a median of -$1.1 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 823.83% — and 2025, when it sank 900.21%.
- Alector's Change in Accured Expenses stood at $4.6 million in 2022, then tumbled by 145.79% to -$2.1 million in 2023, then soared by 420.84% to $6.8 million in 2024, then tumbled by 84.0% to $1.1 million in 2025, then slumped by 1112.21% to -$11.0 million in 2026.
- Business Quant data shows ALEC's Change in Accured Expenses at -$11.0 million in Q1 2026, $1.1 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.77 Mn |
| Jun 30, 2026 | -2.77 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -3.79 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Mar 31, 2025 | -12.72 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 473,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | -10.30 Mn |
| Mar 31, 2024 | -10.30 Mn |